Cardiac Biotech Solutions, Inc. (OTCID: CBSC) (“CBSC” or the “Company”), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products, today provided an update on ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, announced key milestones achieved in 2025, a year defined by progress, innovation, and growth. Vektor's flagship ...

"Publication of the new AMA CPT code represents a significant milestone for Sensydia, and will help foster the adoption of our nninvasive, in-clinic hemodynamic assessment tool by establishing a ...

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

PolyVascular, a medtech company developing a non-surgical heart valve for children with congenital heart disease, has obtained $2 million in funding from non-profit pediatric initiative, CobiCure ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, announced it has received CE Mark for the vMap® System, a non-invasive tool developed with AI that transforms ...

A new technology has been developed that enables cuffless non-invasive blood pressure monitoring by using ultrasonic to track ...

A research team led by Dr. Shin Hur at the Korea Institute of Machinery and Materials (KIMM, President Seog-Hyeon Ryu), ...

Auricular vagal neuromodulation therapy is a non-invasive and non-surgical treatment that could aid cardiovascular disease ...